Compare Illumina, Inc. (ILMN) vs VanEck Rare Earth/Strategic Metals (REMX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs VanEck Rare Earth/Strategic Metals — how do they compare? Illumina, Inc. trades at $278.09 (market cap $39.95B), while VanEck Rare Earth/Strategic Metals trades at $60.99 (market cap $1.75B). The key difference: Illumina, Inc. is far larger — about 22.8× VanEck Rare Earth/Strategic Metals's market cap, and Illumina, Inc. is trading nearer its 52-week high, VanEck Rare Earth/Strategic Metals nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Illumina, Inc. for 83 Days and VanEck Rare Earth/Strategic Metals for 50 Days on average.
| ILMN | REMX | |
|---|---|---|
Market Cap | $39.95B | $1.75B |
Volume | 3,169,503 | 930,523 |
Sector | Health | Sector/Thematic |
52-Week High | $293.69 | $109.53 |
52-Week Low | $91.00 | $60.58 |
Typical Hold Time | 83 Days | 50 Days |
Enterprise Value | $41.31B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $278.17, up 3.89% today and near its 52-week high of $278.99. The stock shows strong technical momentum with bullish moving averages and has beaten earnings estimates for three consecutive quarters. Recent inclusion in the S&P 500 and positive analyst upgrades reflect growing institutional confidence. Revenue remains stable at $4.34B for 2025 with improved profitability, delivering $850M net income after previous losses.
The outlook remains positive with sequencing growth and AI initiatives driving momentum, though elevated valuation ratios and China market headwinds present risks. Analyst consensus leans bullish with 54% buy ratings, but the current price exceeds the $241 consensus target, suggesting near-term consolidation potential before further upside.
REMX, the VanEck Rare Earth and Strategic Metals ETF, trades at $61.00, down 1.42% with a bearish technical signal. The ETF shows extreme oversold conditions with RSI readings near 14, while ADX indicates a strong downtrend. Recent news highlights strategic importance of rare earth metals amid U.S. efforts to reduce dependence on China, though individual holdings like Critical Metals show volatile performance. Bank of America increased its position by 72.1% in the latest quarter, holding 427,651 shares as of August 2026.
The outlook remains challenged by high volatility and China export controls, but strategic positioning for supply chain independence offers long-term potential. Investors face significant price swings with 50% annualized volatility, requiring risk tolerance. The bearish technical setup suggests caution near-term despite oversold conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About VanEck Rare Earth/Strategic Metals
REMX invests in global companies involved in producing, refining, and recycling rare earth and strategic metals. It provides targeted exposure to critical minerals used in high-tech and green energy, with top holdings like Albemarle and Pilbara Minerals.
Read more on REMX →
